Laboratories lag on new anticoagulants

Laboratories lag on new anticoagulants

Coagulation laboratories are set to struggle with a predicted explosion in the uptake of novel anticoagulants, an expert warns.

Expert body endorses renal denervation

Expert body endorses renal denervation

Renal denervation is a step closer to the mainstream, Australian experts say, after the European Society of Cardiology endorsed the radical therapy.

New yearly benchmarks for implanting cardiologists

New yearly benchmarks for implanting cardiologists

Cardiologists involved in the implantation of rhythm-control devices will be required to meet yearly benchmarks in order to maintain their competency in the eyes of the cardiac society.

Patients who stop statin therapy should try again

Patients who stop statin therapy should try again

More than 90% of patients who stop taking statins because of side effects can be successfully restarted on them without further problems, a ‘real-world' study finds.

Controversy flares over chelation results

Controversy flares over chelation results

Controversy has flared over a clinical trial suggesting for the first time that IV “chelation therapy” may have modest cardiovascular benefits.

Latest News

Man’s best friend to the rescue again

Man’s best friend to the rescue again

0

When it comes to heart disease, dogs are again proving to be man's best friend, gaining the official endorsement of the American Heart Association for reducing cardiovascular risk.

Dual-chamber ICDs riskier

Dual-chamber ICDs riskier

0

Dual-chamber ICDs pose a higher risk of complications than single-chamber ICDs in primary prevention patients who have no indications for pacing.

view more
to get Cardiology Update delivered to your inbox

Browse our newsletter archive

Advertisement

Cardiology Update on Twitter

­